Bioray Biotech Co

Bioray Biotech Co Inventory

The Inventory of Bioray Biotech Co (7561.TWO) as of Oct 15, 2026 is 62.08 M TWD. In the previous year, Inventory was 46.27 M TWD — a change of 34.18% (higher).

Inventory

62.08 MTWD

YoY

34.18%

Last updated:

Inventory of Bioray Biotech Co is 2025 62.08 M TWD. Inventory of Bioray Biotech Co was 2024 46.27 M TWD. It decreases by 34.18% higher compared to the previous year.

The Bioray Biotech Co Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
34.80 M TWD
Jan 1, 2019
35.76 M TWD
Jan 1, 2020
48.38 M TWD
Jan 1, 2021
45.56 M TWD
Jan 1, 2022
52.89 M TWD
Jan 1, 2023
55.95 M TWD
Jan 1, 2024
46.27 M TWD
Jan 1, 2025
62.08 M TWD
The Bioray Biotech Co Inventory history
YEARInventoryYoY
62.08 MTWD+34.18%
46.27 MTWD-17.31%
55.95 MTWD+5.78%
52.89 MTWD+16.09%
45.56 MTWD-5.82%
48.38 MTWD+35.30%
35.76 MTWD+2.74%
34.80 MTWD+41.51%
24.59 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bioray Biotech Co Stock analysis

What does Bioray Biotech Co do? Bioray Biotech Co Ltd is a company based in Tainan, Taiwan, operating within the Health Care sector, specifically in the Biotechnology industry. The company went public on July 6, 2020, with its ticker listed as 7561.TWO and ISIN TW0007561B13. Bioray Biotech focuses on the development of biological health products, functional medical testing, and cell storage and preparation services. The company's product portfolio includes personalized probiotics, anti-allergic and intestinal probiotics, diabetes probiotics, and female urinary tract health products. In the functional medical testing segment, the company offers services such as personalized bacteria testing, personalized fungi testing, intestinal normal bacteria analysis, quantitative detection of magnesium in red blood cells, polymorphism analysis of metabolic-related genes, and lymphocyte grouping. For cell storage and preparation, Bioray Biotech provides stem cell storage, immune cell storage, and cytokine-induced killer (CIK) immune cell preparations. The company's website is https://bio-ray.com.tw/, where further information about its services and products can be found. Bioray Biotech is engaged in the development and provision of specialized health-related services and products, primarily targeting personalized health solutions through biotechnology. Bioray Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bioray Biotech Co stock

Inventory of Bioray Biotech Co is 62.08 M TWD in 2025.

Inventory of Bioray Biotech Co changed from 46.27 M TWD to 62.08 M TWD, representing a 34.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Bioray Biotech Co since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Bioray Biotech Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Bioray Biotech Co

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Bioray Biotech Co